Multilevel analysis of systolic blood pressure and ACE gene I/D polymorphism in 438 Swedish families - A public health perspective

BMC Medical Genetics

Volumn 7, Issue , 2006, Pages

  Merlo, Juan ^a,b   Bengtsson Boström, Kristina ^b   Lindblad, Ulf ^b   Råstam, Lennart ^b   Melander, Olle ^c  

^a Department of Health and Health Care Management ^*  (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Malmö University Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG USE; ENVIRONMENTAL FACTOR; FAMILY COUNSELING; FAMILY STUDY; FEMALE; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; HEREDITY; HUMAN; HUMAN CELL; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PARTITION COEFFICIENT; PUBLIC HEALTH SERVICE; SWEDEN; SYSTOLIC BLOOD PRESSURE; VARIANCE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; FAMILY HEALTH; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PUBLIC HEALTH; SWEDEN; SYSTOLE;

EID: 33745621354     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-7-14     Document Type: Article

References (29)

1. Mancia G, Seravalle G, Grassi G: Systolic blood pressure: an underestimated cardiovascular risk factor. J Hypertens 2002, 20(Suppl 5):S21-27.
2. Turner ST, Boerwinkle E: Genetics of blood pressure, hypertensive complications, and antihypertensive drug responses. Pharmacagenomics 2003, 4:53-65.
3. Kureya P, Beevers DG: The mechanisms of hypertension and the role of ACE inhibitors. J Hum Hypertens 1991, 5(Suppl 2): 3-8.
4. Alhenc-Gelas F, Richard JL, Courbon D, Warnet JM, Corvol P: Distribution of plasma angiotensin I-converting enzyme levels in healthy men; relationship to environmental and hormonal parameters. J Lab Clin Med 1991, 117:33-39.
5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
6. Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, Luke A, Chen G, Elston RC, Ward R: Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001, 68:1139-1148,
7. Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F: Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 1996, 58:1268-1278.
8. Rudnichi A, Safar ME, Lajemi M, Benetos A: Gene polymorphisms of the renin-angiotensin system and age-related changes in systolic and diastolic blood pressure in subjects with hypertension. Am J Hypertens 2004, 17:321-327.
9. Safar ME, Lajemi M, Rudnichi A, Asmar R, Benetos A: Angiotensin-converting enzyme D/I gene polymorphism and age-related changes in pulse pressure in subjects with hypertension. Arteriosder Thromb Vasc Biol 2004, 24:782-786.
10. Goldstein H: Multilevel Statistical Models 3rd edition. Hodder Arnold, London; 2003.
11. Rasbash J, Browne W, Goldstein H, Yang M, Plewis I, Healy M, Wood-house G, Draper D, Langford I, Lewis T: Modelling the variance as a function of explanatory variables. A user's guide to MLwiN version 2.1 2000:77-88 [http://multileveliaeacuk/download/usermanpdf]. Multilevels Models Project, Institute of Eduaction, University of London
12. Briollais L, Tzontcheva A, Bull S: Multilevel modeling for the analysis of longitudinal blood pressure data in the Framingham Heart Study pedigrees. BMC Genet 2003, 4(Suppl 1):S19.
13. Burton P, Applications in genetic epidemiology: modellinh correlations within nuclear families using multilevel modelling. Multilevel Modelling Newsletter 1995, 1:5-8.
14. Minisymposium: The Malmo Diet and Cancer Study. Design, biological bank and biomarker programme. 23 October 1991, Malmo, Sweden. J Intern Med 1993, 233:39-79.
15. Berglund G, Eriksson KF, Israelsson B, Kjellstrom T, Lindgarde F, Mattiasson I, Nilsson JA, Stavenow L: Cardiovascular risk groups and mortality in an urban swedish male population: the Malmo Preventive Project. J Intern Med 1996, 239:489-497.
16. Bog-Hansen E, Lindblad U, Bengtsson K, Ranstam J, Melander A. Råstam L: Risk factor clustering in patients with hypertension and NIDDM. The Skaraborg Hypertension Project. J Int Med 1998, 243:223-232.
17. Bengtsson K, Orho-Melander M, Lindblad U. Melander O, Bög-Hansen E, Ranstam J, Råstam L, Groop L: Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and Diabetes Project. J Hypertens 1999, 17:1569-1575.
18. Rastam L, Sjonell G: Measurement of blood pressure with tricuff. Lancet 1991, 337:1162.
19. Sambrooks J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual 2nd edition. NY: Cold Spring Harbour 1989.
20. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCPI) (dipeptidyl carboxypeptidas I). Nucl Acids Res 1992, 20:1433.
21. Shanmugan V, Sell KW, Saha BK: Mistyping ACE heterozygotes. PCR Methods Applications 1993, 3:120-121.
22. Methodology WCCfDS: ATC INdex with DDDs. 1996 [http://aje.oxfordjournals.org/cgi/contenttfull/161/-1/81] Oslo (Norway)
23. Snijders TAB, Bosker RJ: Multilevel analysis: an introduction to basic and advanced multilevel modeling 1st edition. Thousand Oaks, California: SAGE Publications; 1999.
24. Rasbash J, Browne W, Goldstein H, Yang M, Plewis I, Healy M, Wood-house G, Draper D, Langford I, Lewis T: A user's guide to MLwiN version 2.1 edition. Multilevels Models Project, Institute of Eduaction, University of London; 2000.
25. Larsen K, Merlo J: Appropriate assessment of neighborhood effects on individual health -integrating random and fixed effects in multilevel logistic regression. American Journal of Epidemiology 2003 in press.
26. Ben-Shlomo Y, Kuh D: A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 2002, 31: 285-293.
27. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R: The deletion/ insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal disease. J Hypertens 1997, 15:1579-1592.
28. Malats N, Calafell F: Basic glossary on genetic epidemiology. J Epidemiol Community Health 2003, 57:480-482.
29. Schwartz GL, Turner ST: Pharmacogenetics of antihypertensive drug responses. Am J Pharmacogenomics 2004, 4:151-160.